Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
Pakdaman H, Amini Harandi A, Gharagozli K, Abbasi M, Tabassi A, Ashrafi F, Ghaffarpor M, Sharifi S, Delavar Kasmae H, Assarzadegan F, Arabahmadi M, Behnam B. Pakdaman H, et al. Among authors: abbasi m. Int J Neurosci. 2017 Jun;127(6):501-507. doi: 10.1080/00207454.2016.1198793. Epub 2016 Jul 19. Int J Neurosci. 2017. PMID: 27279451 Clinical Trial.
Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran.
Pakdaman H, Amini Harandi A, Abbasi M, Karimi M, Arami MA, Mosavi SA, Haddadian K, Rezaei O, Sadeghi S, Sharifi G, Gharagozli K, Bahrami P, Ashrafi F, Kasmae HD, Ghassemi A, Arabahmadi M, Behnam B. Pakdaman H, et al. Among authors: abbasi m. Neurol Sci. 2016 Nov;37(11):1773-1778. doi: 10.1007/s10072-016-2661-3. Epub 2016 Jul 11. Neurol Sci. 2016. PMID: 27401807
Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study.
Pakdaman H, Amini Harandi A, Abbasi M, Delavar Kasmaei H, Ashrafi F, Gharagozli K, Assarzadegan F, Behnam B, Arabahmadi M. Pakdaman H, et al. Among authors: abbasi m. Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):136-142. doi: 10.1159/000458521. eCollection 2017 Jan-Apr. Dement Geriatr Cogn Dis Extra. 2017. PMID: 28626468 Free PMC article.
MLC601 in vascular dementia: an efficacy and safety pilot study.
Pakdaman H, Amini Harandi A, Gharagozli K, Abbasi M, Ghaffarpour M, Ashrafi F, Delavar Kasmaei H, Amini Harandi A. Pakdaman H, et al. Among authors: abbasi m. Neuropsychiatr Dis Treat. 2017 Oct 5;13:2551-2557. doi: 10.2147/NDT.S145047. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 29042785 Free PMC article.
Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.
Amanlou M, Siadat SD, Ebrahimi SE, Alavi A, Aghasadeghi MR, Ardestani MS, Shanehsaz S, Ghorbani M, Mehravi B, Shafiee Alavidjeh M, Jabbari-Arabzadeh A, Abbasi M. Amanlou M, et al. Among authors: abbasi m. Int J Nanomedicine. 2011;6:747-63. doi: 10.2147/IJN.S17648. Epub 2011 Apr 11. Int J Nanomedicine. 2011. PMID: 21589643 Free PMC article.
1,307 results